BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OptikNow - ECPv6.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.optiknow.ca
X-WR-CALDESC:Events for OptikNow
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230221T160000
DTEND;TZID=America/Toronto:20230221T171500
DTSTAMP:20260422T133213
CREATED:20230125T185540Z
LAST-MODIFIED:20230125T185540Z
UID:99477-1676995200-1676999700@www.optiknow.ca
SUMMARY:The Age-Related Macular Degeneration (AMD) Clinical Trial Landscape
DESCRIPTION:Join FBC this February to raise awareness during AMD-Awareness month! \nAge-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 55\, affecting approximately 2.5 million Canadians. \nIn this new webinar\, we will sit down with Dr. Tom Sheidow for a discussion about the current state of therapies for dry and wet AMD. We will cover types of treatments\, treatment outcomes and what is coming in the future. \nThere will be time for audience questions. You can ask them live\, or email us in advance at education@fightingblindness.ca.
URL:https://www.optiknow.ca/event/the-age-related-macular-degeneration-amd-clinical-trial-landscape/
LOCATION:Virtual
CATEGORIES:Virtual Event
ATTACH;FMTTYPE=image/png:https://www.optiknow.ca/wp-content/uploads/2023/01/download.png
END:VEVENT
END:VCALENDAR